Loading clinical trials...
Loading clinical trials...
Intraoperative Molecular Imaging Of Pulmonary Nodules By SGM-101, A Fluorochrome-Labeled Anti-Carcino-Embryonic Antigen (CEA) Monoclonal Antibody
Conditions
Interventions
SGM-101
Near infrared camera imaging system
Locations
1
United States
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
July 8, 2020
Primary Completion Date
February 10, 2022
Completion Date
February 10, 2022
Last Updated
June 16, 2022
NCT07177937
NCT05671510
NCT06043817
NCT06426511
NCT06257264
NCT06498635
Lead Sponsor
Sunil Singhal
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions